10 Affordable Biotech Stocks to Buy Right Now
On July 6, BioPharma Dive reported that drug developers producing new medicines for the treatment of autoimmune disorders and cancer accounted for more than 40% of venture financing...
Posts Tagged ‘Viking Therapeutics Inc. (NASDAQ:VKTX)’
Viking Therapeutics (VKTX) Soars Higher — Medicare Could Hold The Answer
Viking Therapeutics extended its winning streak to an 8th consecutive day on Tuesday, as investors gobbled up shares amid the growing appetite for the weight loss market, thanks...
10 Resilient Stocks Beating Market Slump
Ten stocks stood firmer on Tuesday, defying a bloodbath in the broader market dragged by a steep technology selloff, with investors placing bets on their shares amid their rosy...
10 Best Mid-Cap Stocks That Could Double Your Money
In this article, we will take a look at some of the best mid-cap stocks that are currently offering at least 100% upside potential to investors.
10 Best Biotech Stocks with Highest Upside Potential
On April 16, reports from J.P. Morgan's biopharma and medtech venture and licensing studies indicated that the capital markets began the year 2026 with selective strength.
20 Stocks Jim Cramer Wanted You To Sell & Immediately Get Out Of
In this article, we will discuss: 20 Stocks Jim Cramer Wanted You To Sell & Immediately Get Out Of .
Jim Cramer’s Hottest GLP-1 and Weight Loss Stock Picks
In this article, we will discuss: Jim Cramer's Hottest GLP-1 and Weight Loss Stock Picks.
Is Viking Therapeutics (VKTX) One of the Shorted Biotech Stocks to Invest in
On February 12, Michael Ulz from Morgan Stanley reduced his price target on Viking Therapeutics Inc. (NASDAQ:VKTX) from $102 to $99.
10 Most Shorted Biotech Stocks to Buy According to Hedge Funds
On February 5, J.P. Morgan shared its views on trends that are expected to define healthcare in 2026.
Raymond James Lowers Viking Therapeutics, Inc. (VKTX) Price Target Amid Optimistic Clinical Initiative Outlook
Viking Therapeutics, Inc. (NASDAQ:VKTX) ranks among the most shorted stocks to buy according to analysts.
11 Most Shorted Stocks to Buy According to Analysts
Although holes are starting to form, the stock market doesn't seem to be in danger of crashing just yet, with the S&P 500 down only 1% from its record high.
Viking Therapeutics, Inc. (VKTX) Advances Obesity Drug Development and Expands Metabolic Disease Pipeline
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best US stocks to buy under $50. On January 12, Viking Therapeutics, Inc.
10 Best US Stocks to Buy Under $50
Volatility is on the rise amid a return to tariff-fuelled market pullbacks.
Viking Therapeutics (VKTX) Soars 11.9% on Strong Weight Loss Market Outlook
Viking Therapeutics grew its share prices by 11.89 percent on Wednesday to finish at $34.34 apiece as investors took heart from comments that the weight loss industry appears ...
Jim Cramer Discussed These 11 Stocks and Recent Market Rotation
Jim Cramer, the host of Mad Money, said on Thursday that the market is moving through a familiar rotation in which stocks that led gains previously are now being sold to raise...
Viking Therapeutics (VKTX) Deemed ‘Extremely Attractive’ and Undervalued by Canaccord, Cited as Leader in Obesity Clinical Development
Viking Therapeutics Inc. (NASDAQ:VKTX) is one of the stocks that will double in 2026.
20 Stocks That Will Double in 2026
On December 8, Kevin Mahn of Hennion & Walsh appeared on CNBC's 'Closing Bell Overtime' to discuss the potential for another bullish year, but with more volatility.
This is why Viking Therapeutics, Inc. (VKTX) is a Strong Buy on Wall Street
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best biotech stocks to buy according to Wall Street analysts. On November 20, H.C.
15 Best Biotech Stocks to Buy According to Wall Street Analysts
The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain for the S&P 500 over the same period.
Viking Therapeutics (VKTX) VANQUISH-1 Trial Completes Early, H.C. Wainwright Retains Buy Rating
Viking Therapeutics, Inc. (NASDAQ:VKTX) ranks among the best short squeeze stocks to buy right now. On November 20, H.C.
12 Best Short Squeeze Stocks to Buy Right Now
As the year comes to a close, investors are keeping close tabs on the Federal Reserve's impending policy move, given the US shutdown-induced data shortage.
William Blair Reiterates “Buy” Rating on Viking Therapeutics (VKTX) Following New VK2735 Data
On November 6, 2025, Viking Therapeutics Inc.
15 Stocks Set to Explode in 2026
While the market figures out whether artificial intelligence is driving the next bubble or the next industrial revolution, a quiet rotation of capital into the next wave of growth...
8 Stocks Jim Cramer Was Asked About
“We keep hearing about how the stock market's valuation has reached excessive levels. And as I said at the top of the show, some segments of the market are overvalued.
Viking Therapeutics (VKTX) Receives a Buy from Oppenheimer
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best healthcare stocks with the highest upside. Viking Therapeutics, Inc.
9 Best Healthcare Stocks with the Highest Upside
Talking about how people are feeling the impact of the shutdown, Dr.
Where is Viking Therapeutics (VKTX) Headed According to Analysts?
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best biotech stocks with high potential. H.C.
14 Biotech Stocks with High Potential
On October 1, Evan Seigerman, head of healthcare research at BMO Capital Markets, appeared on CNBC’s “The Exchange” to talk about what the future may be like for healthcare...
BTIG Reiterates a Buy Rating on Viking Therapeutics (VKTX) With a $125 PT
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best strong buy stocks to invest in according to Wall Street.
12 Oversold Growth Stocks to Buy According to Analysts
On September 27, Wharton professor emeritus and WisdomTree senior economist Jeremy Siegel joined CNBC for an interview to discuss the latest PCE report and what the data reveal...
12 Best Strong Buy Stocks to Invest in According to Wall Street
On September 26, Peter Boockvar, chief investment officer at One Point BFG Wealth Partners, appeared on CNBC to talk about the likelihood of the Federal Reserve’s interest rate...
Jim Cramer Shared Insights on These 14 Stocks
“Growth does come… in many forms, and one of them is in retail.
Viking Therapeutics (VKTX) Rebounds on Bargain-Hunting. Are You Missing Out?
Viking Therapeutics bounced back by 5.46 percent on Wednesday to finish at $25.69 apiece as investors resorted to early bargain-hunting to take advantage of its cheap valuations...
Viking Therapeutics (VKTX) Slashes 42% on Huge Clinical Study Dropout Rate
Viking Therapeutics fell by 42.12 percent on Tuesday to close at $24.36 apiece as investors soured on the high dropout rates in its ongoing clinical trial for its experimental...
Viking Therapeutics Rises as Phase 3 Trials and Oral Formulation Progress Accelerate
The clinical-stage biopharmaceutical firm, Viking Therapeutics, Inc. (NASDAQ:VKTX), based in San Diego, develops novel therapies for metabolic and endocrine disorders.
11 Best Short Squeeze Stocks to Buy Now
The latest U.S. tariff wave has created a suitable environment where short squeeze investments will thrive.
Viking Therapeutics Concludes Broad Manufacturing Agreement With CordenPharma To Support Commercialization of VK2735
Viking Therapeutics, Inc. (NASDAQ:VKTX) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Viking Therapeutics, Inc.
11 Best GLP-1 and Weight Loss Stocks to Invest in
GLP-1 medicines are a type of prescription that mimics a natural hormone that regulates blood sugar and appetite.
Viking Therapeutics, Inc. (VKTX) Nears Obesity Drug Breakthrough with Phase 3 VK2735 Trial
Viking Therapeutics, Inc.
11 Best Future Stocks to Buy Now
Over the past year, investors have poured money into cutting-edge technologies like artificial intelligence and electric cars.
12 Oversold NASDAQ Stocks to Buy Now
On July 14, Max Kettner, chief multi-asset strategist at HSBC, appeared on CNBC to talk about the global markets amid trade tensions.
Viking Therapeutics (VKTX) Soars 9.7% on Looming Weight Loss Drug Trial Results
Viking Therapeutics jumped by 9.74 percent on Tuesday to close at $30.19 apiece as investors repositioned portfolios ahead of the expected release of the results of its own weight...
Viking Therapeutics (VKTX) Rises on Expected Developments
We recently published a list of Investors Are Gobbling Up Shares of These 10 Firms.
Was Jim Cramer Right to Favor Another Stock Over Viking Therapeutics (VKTX)?
We recently published a list of Jim Cramer Nailed These 11 Stock Predictions. In this article, we are going to take a look at where Viking Therapeutics, Inc.
Jim Cramer Nailed These 11 Stock Predictions
During a recent episode of Mad Money, Jim Cramer discussed how the recent wave of deregulation by the U.S.
20 Takeover Rumors Hedge Funds Are Buying
Hedge funds tend to pile up on a stock that gains or is expected to gain positive attention in a market.
10 Worst Performing Mid Cap Stocks to Buy According to Analysts
Market analysts are increasingly highlighting mid-cap stocks as a potentially attractive investment opportunity, particularly in the current economic climate.
10 Oversold Biotech Stocks to Buy Now
Biotechnology stocks are among the most volatile in the market, primarily due to the high risks associated with their performance.
15 Stocks That Took a Nosedive in January
Historically, the S&P 500's performance in January sets the pace for the rest of the year.
Jim Cramer’s Thoughts on These 7 Stocks
Jim Cramer, the host of Mad Money, recently revisited one of his core investment principles: "Nobody ever made a dime panicking." He emphasized that, no matter how many times ...
Hedge Fund Resource Center
